セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/06 | 1,475 | 1,475 | 1,407 | 1,416 | -62 | -4.2% | 51,700 |
| 2024/09/05 | 1,482 | 1,519 | 1,460 | 1,478 | -4 | -0.3% | 55,400 |
| 2024/09/04 | 1,460 | 1,510 | 1,456 | 1,482 | -8 | -0.5% | 72,900 |
| 2024/09/03 | 1,450 | 1,515 | 1,450 | 1,490 | +11 | +0.7% | 34,000 |
| 2024/09/02 | 1,492 | 1,501 | 1,464 | 1,479 | -18 | -1.2% | 40,300 |
| 2024/08/30 | 1,535 | 1,540 | 1,480 | 1,497 | -41 | -2.7% | 79,500 |
| 2024/08/29 | 1,533 | 1,542 | 1,490 | 1,538 | +5 | +0.3% | 69,200 |
| 2024/08/28 | 1,525 | 1,544 | 1,511 | 1,533 | -16 | -1% | 48,100 |
| 2024/08/27 | 1,560 | 1,568 | 1,530 | 1,549 | -11 | -0.7% | 61,800 |
| 2024/08/26 | 1,497 | 1,560 | 1,484 | 1,560 | +82 | +5.5% | 105,500 |
| 2024/08/23 | 1,500 | 1,500 | 1,469 | 1,478 | -15 | -1% | 32,500 |
| 2024/08/22 | 1,420 | 1,493 | 1,420 | 1,493 | +71 | +5% | 94,000 |
| 2024/08/21 | 1,437 | 1,472 | 1,412 | 1,422 | -69 | -4.6% | 112,400 |
| 2024/08/20 | 1,424 | 1,494 | 1,424 | 1,491 | +82 | +5.8% | 103,700 |
| 2024/08/19 | 1,420 | 1,461 | 1,400 | 1,409 | -11 | -0.8% | 56,300 |
| 2024/08/16 | 1,397 | 1,420 | 1,388 | 1,420 | +32 | +2.3% | 37,300 |
| 2024/08/15 | 1,391 | 1,412 | 1,363 | 1,388 | -16 | -1.1% | 58,400 |
| 2024/08/14 | 1,445 | 1,445 | 1,388 | 1,404 | -71 | -4.8% | 79,500 |
| 2024/08/13 | 1,370 | 1,480 | 1,365 | 1,475 | +103 | +7.5% | 100,400 |
| 2024/08/09 | 1,364 | 1,386 | 1,339 | 1,372 | +10 | +0.7% | 91,000 |
| 2024/08/08 | 1,290 | 1,376 | 1,281 | 1,362 | +64 | +4.9% | 75,000 |
| 2024/08/07 | 1,292 | 1,345 | 1,278 | 1,298 | -54 | -4% | 168,100 |
| 2024/08/06 | 1,295 | 1,352 | 1,273 | 1,352 | +113 | +9.1% | 90,500 |
| 2024/08/05 | 1,285 | 1,342 | 1,213 | 1,239 | -134 | -9.8% | 203,200 |
| 2024/08/02 | 1,460 | 1,460 | 1,373 | 1,373 | -117 | -7.9% | 142,600 |
| 2024/08/01 | 1,521 | 1,556 | 1,490 | 1,490 | -67 | -4.3% | 102,800 |
| 2024/07/31 | 1,558 | 1,559 | 1,465 | 1,557 | -19 | -1.2% | 160,000 |
| 2024/07/30 | 1,560 | 1,588 | 1,516 | 1,576 | +16 | +1% | 573,700 |
| 2024/07/29 | 1,546 | 1,560 | 1,505 | 1,560 | +43 | +2.8% | 106,100 |
| 2024/07/26 | 1,469 | 1,540 | 1,469 | 1,517 | +40 | +2.7% | 122,800 |
| 2024/07/25 | 1,475 | 1,509 | 1,450 | 1,477 | -16 | -1.1% | 140,200 |
| 2024/07/24 | 1,510 | 1,579 | 1,491 | 1,493 | -17 | -1.1% | 200,400 |
| 2024/07/23 | 1,508 | 1,579 | 1,497 | 1,510 | +30 | +2% | 180,900 |
| 2024/07/22 | 1,598 | 1,598 | 1,473 | 1,480 | -8 | -0.5% | 303,600 |
| 2024/07/19 | 1,523 | 1,549 | 1,481 | 1,488 | -44 | -2.9% | 152,500 |
| 2024/07/18 | 1,575 | 1,594 | 1,523 | 1,532 | -56 | -3.5% | 242,800 |
| 2024/07/17 | 1,418 | 1,610 | 1,418 | 1,588 | +176 | +12.5% | 609,000 |
| 2024/07/16 | 1,400 | 1,420 | 1,393 | 1,412 | +12 | +0.9% | 55,900 |
| 2024/07/12 | 1,356 | 1,435 | 1,339 | 1,400 | +44 | +3.2% | 125,500 |
| 2024/07/11 | 1,419 | 1,447 | 1,349 | 1,356 | -48 | -3.4% | 145,700 |
| 2024/07/10 | 1,439 | 1,451 | 1,389 | 1,404 | -35 | -2.4% | 126,000 |
| 2024/07/09 | 1,389 | 1,446 | 1,383 | 1,439 | +50 | +3.6% | 141,100 |
| 2024/07/08 | 1,350 | 1,419 | 1,350 | 1,389 | +49 | +3.7% | 186,100 |
| 2024/07/05 | 1,350 | 1,360 | 1,315 | 1,340 | -16 | -1.2% | 95,800 |
| 2024/07/04 | 1,354 | 1,406 | 1,335 | 1,356 | +24 | +1.8% | 165,600 |
| 2024/07/03 | 1,350 | 1,376 | 1,319 | 1,332 | -17 | -1.3% | 115,600 |
| 2024/07/02 | 1,358 | 1,372 | 1,315 | 1,349 | +2 | +0.1% | 73,100 |
| 2024/07/01 | 1,342 | 1,373 | 1,336 | 1,347 | +3 | +0.2% | 66,100 |
| 2024/06/28 | 1,336 | 1,374 | 1,336 | 1,344 | +9 | +0.7% | 63,000 |
| 2024/06/27 | 1,365 | 1,366 | 1,335 | 1,335 | -40 | -2.9% | 85,700 |
201～
250
件表示中 / 1389件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 67,100円 | - | - | 0.75% | 52.13倍 | 2.26倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| Ｃｈｏｒｄｉａ | 20,300円 | - | - | 0.00% | - | 4.32倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| ステラファーマ | 38,500円 | +4.8% | - | 0.00% | - | 4.08倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| ラクオリア | 53,100円 | +25.1% | - | 0.00% | - | 2.35倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| キッズバイオ | 22,400円 | - | - | 0.00% | - | 7.98倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
